Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. (HKG:1349)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
2.760
-0.050 (-1.78%)
May 12, 2026, 4:08 PM HKT

HKG:1349 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
1,1351,1471,0561,1961,2891,209
Short-Term Investments
----30-
Cash & Short-Term Investments
1,1351,1471,0561,1961,3191,209
Cash Growth
7.34%8.60%-11.67%-9.35%9.13%-13.46%
Accounts Receivable
281.76297.75469.96620.49679.12672.49
Other Receivables
1.170.311.080.165.141.18
Receivables
282.92298.07471.04620.64684.26673.66
Inventory
34.1233.2147.2743.6540.5335.63
Other Current Assets
8.867.1632.189.2425.19.77
Total Current Assets
1,4611,4861,6071,8692,0691,928
Property, Plant & Equipment
462.6477.25503.53475.33351.51301.92
Long-Term Investments
227.24229.07257.49287.53306.37327.86
Other Intangible Assets
57.6360.8768.6586.3562.3288.46
Long-Term Deferred Tax Assets
131.41131.41133.28100.8785.979.22
Long-Term Deferred Charges
3.844.419.28-43.0936.12
Other Long-Term Assets
2.722.127.557.1857.6219.64
Total Assets
2,3462,3912,5872,8772,9762,781
Accounts Payable
8.936.0710.678.057.438.17
Accrued Expenses
9.67171.35167.5736.8634.6753.78
Short-Term Debt
----101-
Current Portion of Leases
-5.356.16.338.228.68
Current Income Taxes Payable
---1.611.6310.4
Current Unearned Revenue
5.385.418.340.260.31348.87
Other Current Liabilities
171.8757.4558.27451.9520.0998.3
Total Current Liabilities
195.85245.62250.95505.02673.34528.2
Long-Term Leases
7.889.3414.4310.9515.622.59
Long-Term Unearned Revenue
18.4318.9715.852.1534.0440.8
Total Liabilities
222.16273.93281.23518.12722.99591.58
Common Stock
103.66103.66103.66103.66102.9104.3
Additional Paid-In Capital
1,2901,2901,2901,2891,2251,265
Retained Earnings
736.08728.37916.9970.46934.39868.43
Treasury Stock
------40.82
Comprehensive Income & Other
-6.34-6.05-5.55-5.86-5.2-4.05
Total Common Equity
2,1242,1162,3052,3582,2572,193
Minority Interest
0.350.430.711.01-4.08-3.36
Shareholders' Equity
2,1242,1172,3052,3592,2532,190
Total Liabilities & Equity
2,3462,3912,5872,8772,9762,781
Total Debt
7.8814.6920.5317.28124.8131.26
Net Cash (Debt)
1,1271,1321,0361,1791,1941,178
Net Cash Growth
8.51%9.33%-12.12%-1.33%1.43%-14.49%
Net Cash Per Share
1.461.091.001.141.161.13
Filing Date Shares Outstanding
771.161,0371,0371,0371,0291,032
Total Common Shares Outstanding
771.161,0371,0371,0371,0291,032
Working Capital
1,2651,2401,3561,3641,3961,400
Book Value Per Share
2.752.042.222.272.192.12
Tangible Book Value
2,0662,0552,2362,2712,1952,104
Tangible Book Value Per Share
2.681.982.162.192.132.04
Buildings
-396.73368.53199.22198.52198.52
Machinery
-500.03504.91388.63341.74322.86
Construction In Progress
-0.197.2229.96122.3748.9
Source: S&P Global Market Intelligence. Standard template. Financial Sources.